Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewAI Drug Development Platform Formation Bio Raises $372 Million in Series D FundingOn June 26, AI drug development platform Formation Bio secured $372 million in Series D funding. This round was led by a16z. Formation Bio leverages artificial intelligence to drive more efficient drug development and generate more drug candidates. The company plans to use the new funds for two main objectives: acquiring and licensing drug candidates, as well as expanding its AI capabilities.Ophthalmic Gene Therapy R&D Company Beacon Therapeutics Secures $170 Million in Series B FinancingOn July 3, ophthalmic gene therapy R&D company Beacon Therapeutics secured a $170 million Series B financing round led by Forbion. The funds will be used to support the ongoing clinical development of Beacon's lead asset, AGTC-501, for X-Linked Retinitis Pigmentosa, and to generate Phase 1/2 clinical trial data for the company’s dry age-related macular degeneration program.K Health, an Internet Healthcare Service Platform, Secures $50 Million in Equity FinancingOn July 1, K Health, an internet healthcare service platform, secured $50 million in equity financing led by Claure Group. K Health plans to use the new funds to further enhance its AI technology, including exploring how generative AI can be applied to personalized primary care services, and expand its services nationwide through collaborations with more healthcare systems.Form Health, an Obesity Virtual Care Provider, Raises $38 Million in Series B FundingOn June 26, Form Health, an obesity virtual care provider, raised $38 million.YuanForm Health Secures Series B Funding Led by Sound Ventures, with Participation from M13, SignalFire, and Next View VenturesForm Health will use the funds to accelerate collaborations with enterprise partners, support hiring ABOM-certified physicians to provide science-based obesity care, and invest in its telehealth technology platform.Drug Discovery Platform Kanvas Biosciences Secures $12.5 Million in New Round of FinancingOn July 1, drug discovery platform Kanvas Biosciences secured $12.5 million in a new round of financing, co-led by existing investors DCVC and Lions Capital LLC. The funds will be used to further develop the company’s spatial biology platform and advance two novel therapies within its immuno-oncology program, with the goal of submitting an Investigational New Drug (IND) application by 2025.Healthcare Workforce Solutions Provider Stitch PEO Secures $8.75 Million in Seed FundingOn June 10, healthcare workforce solutions provider Stitch PEO secured $8.75 million in seed funding. Stitch aims to improve how independent medical groups manage their employees by offering a comprehensive HR platform specifically tailored to their needs. It meets the HR, payroll, and benefits management demands of small- and medium-sized medical institutions, automating daily tasks and reducing administrative burdens.Digital Insurance Platform Feather Raises €6 Million in FundingOn June 28, digital insurance platform Feather raised €6 million in funding to assist expatriates working and living in Europe. Feather offers a recommendation tool to help individuals understand the insurance they may need, starting with health insurance but also including other options such as life, pet, car, and personal liability insurance.Medical SaaS Platform Developer Synthpop Raises $5.6 Million in Seed FundingOn June 28, healthcare SaaS platform developer Synthpop secured $5.6 million in seed funding. The round was led by Peterson Ventures. Synthpop will use the funds to hire engineers and enhance its ability to provide agile software development and frequent system updates as it expands into various sectors of the healthcare industry. Synthpop plans to showcase the potential of AI to revolutionize healthcare at conferences in 2024.Orthopedic Telehealth Provider Prescribe FIT Raises $4.8 Million in Series A FundingOn July 2, Prescribe FIT, a provider of remote orthopedic care services, secured $4.8 million in Series A funding. The investors in this round included Jim Grote, Tamarind Hill, JobsOhio Growth Capital, seasoned executives, and orthopedic surgeons. The investment will advance the company's mission to improve patient outcomes and well-being through a data-driven personalized approach.Omics and Genetic Testing Analysis Platform Formation Bio Secures Tens of Millions in Pre-A FundingOn July 4, Omics and Genetic Testing Analysis Platform Formation Bio Secures Tens of Millions in Pre-A Round Financing, Exclusively Invested by PuHua Capital. Formation Bio is a leading universal biobreeding platform enterprise in China, specializing in multi-omics testing and big data analysis for animals and plants. The financing will be used to upgrade the multi-omics calculation platform for animal and plant biobreeding and to develop a smart laboratory for biobreeding.Precision Minimally Invasive Laser Therapeutics Developer XinZhu Medical Secures Tens of Millions in Pre-A FundingRecently, Xinzhu Medical, a developer of precision minimally invasive laser diagnosis and treatment products, has raised tens of millions in Pre-A funding, led by Guangzhou Financial Control Fund. The proceeds will mainly be used for the company's new product R&D projects, application for certifications, marketing layout, market promotion, channel construction, brand building, and global intellectual property layout.Full-Chain Solution Provider for DNA Products, Enzyme Technology, Secures Tens of Millions of RMB in Angel Round FundingOn June 28, EnzymeOne Tech, a full-chain solution provider for DNA products, secured tens of millions of RMB in angel funding led by Linear Capital. EnzymeOne Tech is committed to designing enzyme molecular machines for efficient DNA synthesis through the development of protein-nucleic acid interaction algorithms, enabling low-cost, large-scale de novo gene synthesis. The proceeds from this round will primarily be used to advance enzyme-driven DNA synthesis experiments, instrument development, and team building.Digital Medical Diagnosis and Treatment Service Provider Neusoft Healthcare Receives Strategic FinancingOn July 3, Neusoft Medical, a provider of digital medical diagnosis and treatment services, received strategic investment from China General Technology Group. As a concrete practice of cooperation between state-owned enterprises and private enterprises in the development of the high-end medical equipment industry, this strategic partnership marks China General Technology Group's entry into the research and manufacturing of large-scale digital medical equipment, achieving a strategic layout from medical services to medical technology.02 Digital Health Industry DynamicsOMNY Health Partners with Aris Global and Quant HealthOn July 2, healthcare data company OMNY Health announced partnerships with two medical artificial intelligence companiesAris Global and Quant Health Establish Partnership, Marking OMNY's First Step into Artificial Intelligence. The medical field has long lacked a systematic and comprehensive data source. OMNY is committed to creating a nationwide healthcare-related database in China, maintaining a real-time data layer for over 70 million patients, which will aid medical research. In this new round of collaboration, it will also empower the training of healthcare AI.Silo Pharma Collaborates with AmplifyBio to Advance SPC-15 for PTSD and Anxiety DisordersOn June 26, Silo Pharma, a developer of therapies for neurological disorders, announced it has awarded a contract to its Contract Research Organization (CRO) partner, AmplifyBio, to conduct an Investigational New Drug (IND)-enabling large animal GLP (Good Laboratory Practice) study for its lead asset, SPC-15, an intranasal prophylactic treatment for Post-Traumatic Stress Disorder (PTSD).Lilly Collaborates with OpenAI to Discover New Drugs for Treating Drug-Resistant BacteriaOn June 25, Eli Lilly announced a collaboration with OpenAI, which will allow Eli Lilly to utilize OpenAI's generative AI to invent novel antimicrobial agents for treating drug-resistant pathogens. Antimicrobial resistance (AMR) is one of the greatest public health and development threats in the global health sector.03 Global Digital Health M&A OverviewMars Completes Acquisition of Cerba Vet and ANTAGENEOn July 2, Mars completed the acquisition of Cerba Vet, the veterinary diagnostics enterprise of Cerba HealthCare Group in France, as well as shares of ANTAGENE. Headquartered in Massy, France, Cerba Vet primarily provides comprehensive animal-related diagnostic services to veterinary practitioners; ANTAGENE, headquartered in Lyon, France, mainly offers tests for diagnosing pet diseases and supports scientific initiatives for biodiversity protection. The investment in Cerba Vet and ANTAGENE will expand and enhance the accessibility of diagnostic solutions in France, better serving more veterinary professionals and pets.Healthcare Data Analytics Provider Arcadia Announces Acquisition of CareJourneyOn June 27, healthcare data analytics service provider Arcadia acquired CareJourney, a leading provider of clinically relevant healthcare data and AI-driven analytics. This combines Arcadia’s data platform, analytics, and tools with CareJourney’s cost, quality, and benchmark data. The integrated platform will help healthcare organizations perform advanced analytics, develop strategies, and improve patient and financial outcomes.Artery Network/Arterial Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/FierceHealth, etc.
Compiled by: Zhang Qiankun
